AAAAAA

   
Results: 1-20 |
Results: 20
Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance
Authors: Stuart, JWTC Wensing, AMJ Kovacs, C Righart, M de Jong, D Kaye, S Schuurman, R Visser, CJT Boucher, CAB
Citation: Jwtc. Stuart et al., Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance, J ACQ IMM D, 28(2), 2001, pp. 105-113
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up
Authors: Vandamme, AM Houyez, F Banhegyi, D Clotet, B De Schrijver, G De Smet, KAL Hall, WW Harrigan, R Hellmann, N Hertogs, K Holtzer, C Larder, B Pillay, D Race, E Schmit, JC Schuurman, R Shulse, E Sonnerborg, A Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
Authors: Miller, V Vandamme, AM Loveday, C Staszewski, S Lundgren, J Youle, M Ait-Khaled, M Boucher, C Brun-Vezinet, F Dedes, N Giaquinto, C Hertogs, K Houyez, F Perrin, L Pillay, D Schmit, JC Schuurman, R Lange, J Banhegyi, D Biondi, G Broekhuizen, A Bush-Donovan, C Camacho, R Carlier, H Clavel, F Clotet, B Clumeck, N Colebunders, R De Clerq, K De Jaegher, JJ De Schrijver, G De Smet, K Hall, W Harrigan, R Hatzakis, A Hellmann, N Hoetelmans, R Holtzer, C Katlama, C Larder, D Loriaux, E McCreedy, B Mulcahy, F Opravil, M Phillips, A Ruiz, N Shulse, E Sonnerborg, A Soriano, V Steel, H Vella, S Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma
Authors: Caliendo, AM Schuurman, R Yen-Lieberman, B Spector, SA Andersen, J Manjiry, R Crumpacker, C Lurain, NS Erice, A
Citation: Am. Caliendo et al., Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma, J CLIN MICR, 39(4), 2001, pp. 1334-1338
Simultaneous detection of influenza viruses A and B using real-time quantitative PCR
Authors: van Elden, LJR Nijhuis, M Schipper, P Schuurman, R van Loon, AM
Citation: Ljr. Van Elden et al., Simultaneous detection of influenza viruses A and B using real-time quantitative PCR, J CLIN MICR, 39(1), 2001, pp. 196-200
Blinded, multicenter quality control study for the quantification of humanimmunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories
Authors: Muyldermans, G Debaisieux, L Fransen, K Marissens, D Miller, K Vaira, D Vandamme, AM Vandenbroucke, AT Verhofstede, C Schuurman, R Zissis, G Lauwers, S
Citation: G. Muyldermans et al., Blinded, multicenter quality control study for the quantification of humanimmunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories, CL MICRO IN, 6(4), 2000, pp. 213-217
Carbamazepine-indinavir interaction causes antiretroviral therapy failure
Authors: Hugen, PWH Burger, DM Brinkman, K ter Hofstede, HJM Schuurman, R Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Carbamazepine-indinavir interaction causes antiretroviral therapy failure, ANN PHARMAC, 34(4), 2000, pp. 465-470
2,2 '-bipyridine lariat calixcrowns: A new class of encapsulating ligands forming highly luminescent Eu3+ and Tb3+ complexes
Authors: Fischer, C Sarti, G Casnati, A Carrettoni, B Manet, I Schuurman, R Guardigli, M Sabbatini, N Ungaro, R
Citation: C. Fischer et al., 2,2 '-bipyridine lariat calixcrowns: A new class of encapsulating ligands forming highly luminescent Eu3+ and Tb3+ complexes, CHEM-EUR J, 6(6), 2000, pp. 1026-1034
In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors
Authors: Back, NKT van Wijk, A Remmerswaal, D van Monfort, M Nijhuis, M Schuurman, R Boucher, CAB
Citation: Nkt. Back et al., In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors, AIDS, 14(1), 2000, pp. 101-102
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
Authors: Van Vaerenbergh, K Van Laethem, K Albert, J Boucher, CAB Clotet, B Floridia, M Gerstoft, J Hejdeman, B Nielsen, C Pannecouque, C Perrin, L Pirillo, MF Ruiz, L Schmit, JC Schneider, F Schoolmeester, A Schuurman, R Stellbrink, HJ Stuyver, L Van Lunzen, J Van Remoortel, B Van Wijngaerden, E Vella, S Witvrouw, M Yerly, S De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Evaluation of automated nucleic acid extraction devices for application inHCVNAT
Authors: Jongerius, JM Bovenhorst, M van der Poel, CL van Hilten, JA Kroes, ACM van der Does, JA van Leeuwen, EF Schuurman, R
Citation: Jm. Jongerius et al., Evaluation of automated nucleic acid extraction devices for application inHCVNAT, TRANSFUSION, 40(7), 2000, pp. 871-874
Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection
Authors: Frost, SDW Nijhuis, M Schuurman, R Boucher, CAB Brown, AJL
Citation: Sdw. Frost et al., Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection, J VIROLOGY, 74(14), 2000, pp. 6262-6268
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
Authors: Van Laethem, K Van Vaerenbergh, K Schmit, JC Sprecher, S Hermans, P De Vroey, V Schuurman, R Harrer, T Witvrouw, M Van Wijngaerden, E Stuyver, L Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Effect of weekly adefovir (PMEA) infusions on HIV-1 virus load: results ofa Phase I/II study
Authors: Kamp, W Schokker, J Cambridge, E De Jong, S Schuurman, R De Groot, T Boucher, CAB
Citation: W. Kamp et al., Effect of weekly adefovir (PMEA) infusions on HIV-1 virus load: results ofa Phase I/II study, ANTIVIR TH, 4(2), 1999, pp. 101-107
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)
Authors: Stuart, JWTC Schuurman, R Burger, DM Koopmans, PP Sprengers, HG Juttmann, JR Richter, C Meenhorst, PL Hoetelmans, RMW Kroon, FP Bravenboer, B Hamann, D Boucher, CAB Borleffs, JCC
Citation: Jwtc. Stuart et al., Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study), AIDS, 13(7), 1999, pp. F53-F58
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
Authors: Nijhuis, M Schuurman, R de Jong, D Erickson, J Gustchina, E Albert, J Schipper, P Gulnik, S Boucher, CAB
Citation: M. Nijhuis et al., Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy, AIDS, 13(17), 1999, pp. 2349-2359
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
Authors: Casado, JL Arrizabalaga, J Montes, M Marti-Belda, P Tural, C Pinilla, J Gutierrez, C Portu, J Schuurman, R Aguirrebengoa, K
Citation: Jl. Casado et al., Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy, AIDS, 13(12), 1999, pp. 1497-1502
Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential
Authors: Keulen, W van Wijk, A Schuurman, R Berkhout, B Boucher, CAB
Citation: W. Keulen et al., Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential, AIDS, 13(11), 1999, pp. 1343-1349
HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study
Authors: Aboulker, JP Babiker, AG Brun-Vezinet, F Darbyshire, JH Flandre, P Gazzard, B Nunn, AJ Goodall, R Aber, V Bragman, K Breckenridge, AM Carbon, C Charreau, I Chene, G Collis, P Cooper, D Dormont, J Fiddian, P Flepp, M Goebel, FD Hooker, M Lange, J Luthy, R Peto, TEA Reiss, P Seligmann, M Stone, AB Thomis, J Vella, S Walckenaer, G Warrell, D Weller, IVD Wilber, R Yeni, P Yeo, J Withnall, R Goudsmit, J Huraux, JM van der Noorda, J Weiss, R Boucher, C Schuurman, R Descamps, D Jeffries, D Tedder, R Weber, J Krzyanowski, C Weverling, G
Citation: Jp. Aboulker et al., HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study, AIDS, 13(1), 1999, pp. 57-65
Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase
Authors: Schuurman, R Demeter, L Reichelderfer, P Tijnagel, J de Groot, T Boucher, C
Citation: R. Schuurman et al., Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase, J CLIN MICR, 37(7), 1999, pp. 2291-2296
Risultati: 1-20 |